ATE435915T1 - Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria - Google Patents

Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria

Info

Publication number
ATE435915T1
ATE435915T1 AT04016071T AT04016071T ATE435915T1 AT E435915 T1 ATE435915 T1 AT E435915T1 AT 04016071 T AT04016071 T AT 04016071T AT 04016071 T AT04016071 T AT 04016071T AT E435915 T1 ATE435915 T1 AT E435915T1
Authority
AT
Austria
Prior art keywords
neisseria
polypeptides
nucleic acids
specific nucleic
disease causing
Prior art date
Application number
AT04016071T
Other languages
English (en)
Inventor
Luc Aujame
Annabelle Bouchardon
Genevieve Renauld-Mongenie
Bachra Rokbi
Xavier Nassif
Colin Tinsley
Agnes Perrin
Original Assignee
Sanofi Pasteur
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur, Inst Nat Sante Rech Med filed Critical Sanofi Pasteur
Application granted granted Critical
Publication of ATE435915T1 publication Critical patent/ATE435915T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04016071T 1998-10-30 1999-10-28 Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria ATE435915T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9813693A FR2785293B1 (fr) 1998-10-30 1998-10-30 Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria

Publications (1)

Publication Number Publication Date
ATE435915T1 true ATE435915T1 (de) 2009-07-15

Family

ID=9532223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04016071T ATE435915T1 (de) 1998-10-30 1999-10-28 Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria

Country Status (8)

Country Link
US (4) US6835384B1 (de)
EP (4) EP1129195A2 (de)
AT (1) ATE435915T1 (de)
AU (1) AU775986B2 (de)
CA (1) CA2349495A1 (de)
DE (1) DE69941099D1 (de)
FR (1) FR2785293B1 (de)
WO (1) WO2000026375A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
ATE527360T1 (de) 1998-12-08 2011-10-15 Glaxosmithkline Biolog Sa Neue verbindungen abgeleitet von neisseria meningitidis
GB9902070D0 (en) * 1999-01-29 1999-03-24 Smithkline Beecham Biolog Novel compounds
GB0103424D0 (en) 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
WO2012059593A1 (en) * 2010-11-05 2012-05-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccines for preventing meningococcal infections
AU2013295242C1 (en) 2012-07-27 2018-08-09 Institut National De La Sante Et De La Recherche Medicale CD147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
WO2017137085A1 (en) 2016-02-11 2017-08-17 Sanofi Pasteur Meningitidis vaccines comprising subtilinases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952496A (en) 1984-03-30 1990-08-28 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5028530A (en) 1985-01-28 1991-07-02 Xoma Corporation AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5147800A (en) * 1990-06-08 1992-09-15 Life Technologies, Inc. Host expressing ngoaiii restriction endonuclease and modification methylase from neisseria
FI903414A7 (fi) * 1990-07-06 1992-01-07 Kansanterveyslaitos Produktion av proteiner i grampositiva bakterier.
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
FR2682114B1 (fr) * 1991-10-03 1996-02-23 Pasteur Merieux Serums Vacc Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
CA2131620A1 (en) 1992-03-20 1993-09-30 Louis C. Smith A dna transporter system and method of use
DK0636028T3 (da) 1992-04-03 2004-07-12 Univ California Selvorganiserende polynucleotidleveringssystem omfattende et amfipatisk kationisk peptid
AU675702B2 (en) 1993-01-26 1997-02-13 Leslie R. Coney Compositions and methods for delivery of genetic material
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
SG54115A1 (en) 1993-04-27 1998-11-16 Gerber Scient Products Inc Thermal printing apparatus with improved power supply
EP0708637B1 (de) 1993-07-14 2004-01-28 The Regents of the University of California Sich selbst zusammensetzendes polynukleotid-abgabesystem, das dendrimer-polykationen enthält
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6121037A (en) * 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
FR2751000B1 (fr) * 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
EP0839909A1 (de) * 1996-10-29 1998-05-06 Rijksuniversiteit te Groningen Nukleinsäuresequenzen die für Citrat-Transporterproteine Kodieren
US5912143A (en) * 1996-12-27 1999-06-15 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a human mage protein homolog

Also Published As

Publication number Publication date
EP2100960A3 (de) 2009-12-02
US7704513B2 (en) 2010-04-27
DE69941099D1 (de) 2009-08-20
US7384768B2 (en) 2008-06-10
EP2100960A2 (de) 2009-09-16
WO2000026375A3 (fr) 2000-08-17
AU6347999A (en) 2000-05-22
US8309100B2 (en) 2012-11-13
AU775986B2 (en) 2004-08-19
WO2000026375A2 (fr) 2000-05-11
EP1475441A3 (de) 2005-05-04
US20050032103A1 (en) 2005-02-10
US20100184639A1 (en) 2010-07-22
US6835384B1 (en) 2004-12-28
CA2349495A1 (en) 2000-05-11
EP1475441B1 (de) 2009-07-08
EP1724352A2 (de) 2006-11-22
EP1475441A2 (de) 2004-11-10
FR2785293A1 (fr) 2000-05-05
EP1129195A2 (de) 2001-09-05
US20090155886A1 (en) 2009-06-18
EP1724352A3 (de) 2007-07-11
FR2785293B1 (fr) 2002-07-05

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
ATE312920T1 (de) Dna immunisierung gegen chlamydia infektion
FR17C1046I2 (fr) Nouvelles molecules b7-4 et leurs utilisations
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
WO2001073059A3 (en) 38692 and 21117: dual specificity phosphatase molecules and uses therefor
BR7908410A (pt) Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
BR0015137A (pt) Peptìdeos antigênicos de neisseria
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
DE60035517D1 (de) Gl50 moleküle, sowie verwendungen derselben
Meehan et al. Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. equi
NO20011381L (no) Preparater av streptokokk C<beta>-protein
ATE435915T1 (de) Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria
ATE299182T1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
Kataoka et al. Secretion of functional salivary peptide by Streptococcus gordonii which inhibits fimbria-mediated adhesion of Porphyromonas gingivalis
ATE480620T1 (de) Neue pgc-1-isoformen und deren verwendungen
Lim et al. Potentiation of antigen‐specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon‐γ hybrid construct
Lee et al. Identification of a point mutation resulting in loss of cell wall anchoring activity of SrtA of Streptococcus mutans NG5
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
Kamachi et al. Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization
KLEPPE Characterization of the h1 protein antigen from Staphylococcus aureus 17A
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
FI963016A0 (fi) Heterologisten proteiinien ilmentäminen heikennetyissä bakteereissa käyttämällä htrA-promoottoreita
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
EP0949333A4 (de) Mutierte antigene des masernvirus und die dafür kodierenden gene.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties